Inhibrx (INBX) Stock Chart & Stock Price History $14.04 -0.25 (-1.75%) (As of 11/20/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Inhibrx Stock Price Performance 5 Day Performance+1.52%1 Month Performance-9.42%3 Month Performance+7.59%6 Month Performance-59.00%Year-To-Date Performance-63.05%1 Year Performance-28.93% Receive INBX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibrx and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump won. Buy this coin now. (Ad)Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will go to $150,000 — or more. But there’s one coin he thinks could go even higher.This could be his favorite coin. INBX Stock Chart for Thursday, November, 21, 2024 INBX Chart by TradingView Inhibrx Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/20/2024$14.29$14.04-1.75%$14.34$13.9389,940 shs$203.30 million11/19/2024$13.62$14.29+4.92%$14.49$13.27131,729 shs$206.92 million11/18/2024$13.83$13.62-1.52%$14.05$13.5299,447 shs$200.20 million11/15/2024$14.33$13.83-3.49%$14.77$12.25178,264 shs$200.26 million11/14/2024$15.45$14.33-7.25%$15.59$14.17112,449 shs$223.65 million11/13/2024$16.58$15.45-6.82%$17.05$15.4340,114 shs$223.72 million Get the Latest News and Ratings for INBX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibrx and its competitors with MarketBeat's FREE daily newsletter. 11/12/2024$16.00$16.58+3.62%$17.41$15.86130,795 shs$240.08 million11/11/2024$16.21$16.00-1.30%$16.60$15.9756,061 shs$231.68 million11/08/2024$16.26$16.21-0.31%$16.63$15.9779,016 shs$234.72 million11/07/2024$16.05$16.26+1.31%$16.68$16.1668,569 shs$235.45 million11/06/2024$15.71$16.05+2.16%$16.79$15.5894,990 shs$232.34 million11/05/2024$15.55$15.71+1.03%$15.71$15.2433,984 shs$227.48 million11/04/2024$15.80$15.55-1.58%$15.85$15.4128,638 shs$225.16 million11/01/2024$16.03$15.80-1.43%$16.49$15.6538,936 shs$228.78 million10/31/2024$16.29$16.03-1.60%$16.35$16.0035,220 shs$232.05 million10/30/2024$16.10$16.29+1.18%$16.44$16.0336,111 shs$235.81 million10/29/2024$16.00$16.10+0.63%$16.43$15.9437,032 shs$233.06 million10/28/2024$15.37$16.00+4.10%$16.31$15.6446,620 shs$231.68 million10/25/2024$15.37$15.37$15.79$15.3426,632 shs$222.50 million10/24/2024$15.76$15.37-2.47%$15.89$15.3021,216 shs$222.50 million10/23/2024$15.80$15.76-0.25%$15.87$15.3233,577 shs$228.14 million10/22/2024$15.50$15.80+1.94%$16.00$15.3128,290 shs$228.72 million10/21/2024$16.00$15.50-3.13%$15.95$15.5020,253 shs$224.38 million Related Companies Pieris Pharmaceuticals Stock Price Chart Tyra Biosciences Stock Price Chart Rapport Therapeutics Stock Price Chart Relay Therapeutics Stock Price Chart Erasca Stock Price Chart Autolus Therapeutics Stock Price Chart Evolus Stock Price Chart Pliant Therapeutics Stock Price Chart Cronos Group Stock Price Chart Cullinan Therapeutics Stock Price Chart Receive INBX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibrx and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:INBX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibrx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibrx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.